Frankfurt Rhine-Main Metropolitan Area
Indenpent advisor/consultant, highly qualified with more then 30 years experience in pharmaceutical industry especially in the blood plasma business, plasma fractionation and purification of plasma proteins, operating of production plants, development labs and engineering departments. External project manager for an investment programme („Biotest Next Level“~ € 250 million) at Biotest . This programme includes the construction of a basic fractionation plant , bulk production facilities for Albumin, IgG, Fibrinogen and IgM-concentrate, storage facilities for Plasma andQC-Labs. Conceptual study for a new plasma fractionation plant including purification facilities for albumin, IgG, different clotting factors, filling and packaging, QC labs, plasma warehouse, generell warehouse etc. for a chinese customer. Advise in different smaller GMP- and technical projects Stratetic advise in the plasma product business for different costumers
Biotest Germany : Senior Vice President Manufacturing Operations(authorised officer) responsible for all manufacturing operations in Germany as well as at cooperation partners like CAF-DCF in Belgium, Kedrion in Italy and Hungary, CAF-DCF Belgium, Sanquin in Netherlands responsible for 250 employees Strategical reorganisation of manufacturing operations Enlargement of the production capacity Extension and upgrade of the filling, lyophilisation, formulation and packaging facilities (Investment: ~ € 33 million) New (second)IgG purification facilitiy (Investment: ~ € 15 million) New (second)Albumin purification facility Investment: ~ € 7 million) New plasma ware house with PCR labs (Investment ~ €18 Million) Co -Initiator of the investment program „Biotest Next Level“
Biotest Germany: Senior Director Bulkproduction responsible for all bulk production operations in Germany responsible for 100 employees Reorganisation of the department Extension and (GMP and technical)upgrade of different bulk production facilities New plasma (basic) fractionation and Albumin purification facility (investment: ~ € 12 million) New IgG purification facility (investment ~ € 8 million) New clotting factors purification facilities (investment ~ € 8 million Implementation of different new production processes and technique(IgG, basic fractionation process, Albumin, Factor VIII, Factor IX) Responsible for process transfer to different international partners
Octapharma Austria: Head of Production and Engineering (authorised officer) responsible for all manufacturing and engineering operations in Austria responsible for 50 employees Operational and organisationel structuring of the departments production and QC Implementation of quality assurance tools into the organisation Organisational integration of the engineering and maintance group into the production department Extension and upgrade(GMP and technical) of the production department Implementation of different new production processes and technique( Basic fractionation process, Albumin, Factor VIII, PPSB, IgG) Responsible for process transfer to different international partners